The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a specialized academic medical center in Houston, Texas, dedicated exclusively to cancer care, cancer research, cancer prevention, and the education of health professionals. It is one of the principal institutions of the Texas Medical Center and is a component of The University of Texas System. The center is named for Monroe Dunaway Anderson, a Houston banker and cotton merchant whose philanthropic legacy helped make its creation possible. The institution originated in 1941, when the former site of a U.S. Army barracks in Houston was converted into a cancer hospital and research facility associated with The University of Texas. Its early development reflected a model that combined patient treatment with laboratory investigation and physician training. As its research capabilities and clinical capacity expanded, MD Anderson became a major referral center for complex and rare cancers, accepting patients from across the United States and from other countries. Its work spans medical, surgical, and radiation oncology; hematologic malignancies; pediatric cancer; transplantation and cellular therapy; diagnostic pathology; imaging; supportive and palliative care; cancer genetics; survivorship; and prevention. The center also operates extensive laboratory and translational research programs covering cancer biology, immunology, genomics, drug development, early detection, health disparities, and population science. Clinical trials are a central part of its research and care model, including studies of new medicines, immunotherapies, radiation approaches, surgical techniques, diagnostics, and combinations of treatments. MD Anderson is also an educational institution. It trains medical students, residents, fellows, graduate students, nurses, scientists, and other health professionals, while providing continuing education for cancer-care practitioners. Through prevention and population-health programs, it works on tobacco control, screening, risk reduction, early diagnosis, and community outreach. The institution's international activities have included clinical and research collaborations, education, consulting, and partnerships intended to extend specialized oncology knowledge beyond Houston. The center is not a conventional consumer product brand or medical-device manufacturer. Its public identity is built primarily around institutional reputation, specialist expertise, clinical outcomes, research leadership, and the promise of multidisciplinary cancer care. It remains an active, state-affiliated academic cancer center and a major employer and research organization within Houston's medical ecosystem.

MD Anderson's institutional history began with a gift and a public-health vision. Monroe Dunaway Anderson, a Houston businessman and philanthropist, left funds that supported the development of medical and educational institutions in Texas. In 1941, The University of Texas established a cancer hospital and research facility in Houston using a former military barracks site. The new institution was named the M. D. Anderson Hospital for Cancer Research in recognition of Anderson's contribution. From its earliest years, the center was organized around the integration of clinical care, scientific research, and professional education. This structure distinguished it from a general hospital and allowed specialists to focus on cancer biology and treatment. The facility later became part of the growing Texas Medical Center, where proximity to other hospitals, universities, and research organizations supported the development of multidisciplinary care and collaborative investigation. During the second half of the twentieth century, the center expanded its clinical specialties, laboratories, training programs, and referral network. It developed major capabilities in surgery, radiation oncology, medical oncology, hematology, pathology, imaging, pediatric cancer, transplantation, and supportive care. The institution also became associated with the National Cancer Institute's designated cancer-center network, reflecting its role in cancer research and advanced patient care. As cancer medicine changed, MD Anderson broadened its research portfolio from conventional surgery, chemotherapy, and radiation to molecular oncology, genetics, immunology, targeted therapy, immunotherapy, precision medicine, early detection, and population science. Its clinical-trial infrastructure became an important mechanism for moving discoveries from laboratory research into patient treatment. The center also developed programs addressing prevention, tobacco control, screening, survivorship, symptom management, and cancer-related health disparities. In the twenty-first century, institutional strategy increasingly emphasized large-scale, cross-disciplinary programs intended to reduce cancer mortality and accelerate translation. The Moon Shots Program, launched in 2012, organized substantial research and clinical activity around selected cancers and cross-cutting scientific problems. The program's goals included earlier detection, better prevention, more effective treatment, and faster conversion of discoveries into clinical practice. MD Anderson has also pursued an international and educational role through partnerships, professional training, research collaboration, and the dissemination of clinical expertise. Its operations remain centered in Houston, but patients, trainees, research collaborators, and referring physicians come from a broad geographic area. The institution continues to function as a component of The University of Texas System rather than as a separately listed company. Its present identity combines a high-volume specialty hospital, a biomedical research organization, a graduate and professional education center, and a public-facing cancer-prevention institution.

• 2012

  Moon Shots Program launched

  [3]MD Anderson Moon Shots Programmdanderson.org

  MD Anderson introduced a large-scale initiative designed to accelerate progress in prevention, early detection, research, and treatment across selected cancers.

• 1971

  National Cancer Act expands the national cancer-center system

  [4]National Cancer Institute cancer centerscancer.gov

  Federal cancer policy created the modern National Cancer Institute cancer-center framework in which institutions such as MD Anderson became major research and care centers.

• 1941

  Cancer hospital established in Houston

  [1]MD Anderson historymdanderson.org

  The University of Texas established the cancer hospital and research facility that became MD Anderson on a former military barracks site in Houston.

A comprehensive, research-intensive academic cancer center specializing exclusively in cancer care, discovery, education, prevention, and complex-case referral.

• Healthcare services · 1941

  Cancer clinical care

  MD Anderson provides multidisciplinary diagnosis and treatment for adult and pediatric cancers. Services include medical oncology, surgery, radiation oncology, hematology, transplantation and cellular therapy, pathology, imaging, symptom management, rehabilitation, palliative care, and survivorship. Care is organized around disease-specific and specialty programs, with complex cases often reviewed by teams spanning multiple disciplines.

• Research and healthcare services

  Cancer clinical trials

  Clinical trials are a core institutional offering, covering investigational drugs, immunotherapies, targeted treatments, radiation methods, surgical approaches, diagnostics, prevention strategies, and combinations of established and experimental therapies. The program connects laboratory discoveries with eligible patients while also supporting studies of cancer biology, quality of life, and survivorship.

• Biomedical research · 1941

  Cancer research and drug development

  The center conducts basic, translational, and clinical research in cancer genetics, genomics, immunology, tumor biology, drug discovery, early detection, prevention, population science, and health disparities. Research programs are intended to move findings from laboratory models into diagnostic tools, therapies, prevention interventions, and improved clinical practice.

• Public health services

  Cancer prevention and early detection

  Prevention programs address modifiable cancer risks, tobacco use, screening, early diagnosis, cancer education, and community health. The institution also conducts population research and outreach intended to reduce unequal access to prevention and early-detection services.

• Education and training · 1941

  Professional and graduate education

  MD Anderson trains physicians, nurses, scientists, and other healthcare professionals through residencies, fellowships, graduate education, research appointments, clinical instruction, and continuing education. Education is integrated with the center's clinical and laboratory programs.

• 2012Moon Shots Program

  United States · International

  A major institutional research and clinical initiative focused on accelerating progress against selected cancers and cross-cutting problems such as prevention, early detection, treatment resistance, and metastatic disease.

  Outcome. The program became a prominent organizing platform for MD Anderson's translational research, clinical innovation, philanthropy, and public communication.

  Source

• 2012

  Launch of the Moon Shots research strategyStrategy

  Background

  MD Anderson sought to organize substantial scientific, clinical, and philanthropic resources around faster reductions in cancer mortality and more rapid translation of discoveries.

  Action taken

  The institution established the Moon Shots Program around selected cancers and scientific priorities, combining research, prevention, early detection, clinical trials, and data-driven collaboration.

  Aftermath

  The program became a central part of the center's institutional identity and research-development strategy.

  Source

1. 1MD Anderson historymdanderson.org
2. 2MD Anderson leadershipmdanderson.org
3. 3MD Anderson Moon Shots Programmdanderson.org
4. 4National Cancer Institute cancer centerscancer.gov